Summit Therapeutics
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.
Last updated on
About Summit Therapeutics
Estimated Revenue
$1M-$10MEmployees
51-250Category
Location
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (21)
